K. C. Channappa1, Yogeesha K. S2
INTRODUCTION
Two of the most dreaded diseases of the 21st century are cancer and HIV. It brings shiver down the spines of a treating physician because of the complexity of the diseases. One important way of doing this is serum albumin which is most commonly used. In recent years, the role of malnutrition as a predictor of survival in cancer has received considerable attention. As a result, it is reasonable to investigate whether serum albumin has utility as a prognostic indicator of cancer survival in cancer. This review summarizes all available epidemiological literature on the association between pretreatment serum albumin levels and survival in different types of cancer. Pretreatment serum albumin levels provide useful prognostic significance in cancer.
